Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in SYRE — Spyre Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$157,837,877
+$95,892,867 QoQ
Shares Held
1,777,854
+44.8% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. SYRE ranks #13 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $157,837,877 1,777,854
2026-03-31 $61,945,010 1,228,093
2025-12-31 $13,750,255 419,727
2025-09-30 $5,778,897 344,803
2025-06-30 $5,933,373 396,351
2025-03-31 $6,890,854 427,075
2024-12-31 $166,265 7,142
2024-09-30 $7,581,809 257,797
2024-06-30 $4,494,383 191,169
2024-03-31 $1,378,072 36,332